UB, partner awarded $3 million NIH grant to study immune cell therapy for tumors

The work could improve a promising type of immunotherapy
treatment — chimeric antigen receptor (CAR) T-cell
therapy.

Related articles

FLASH Ticket Giveaway: Cut Copy!

Cut Copy are making their way through Buffalo, performing...

What Trump’s Mamdani praise — and MTG’s ouster — says about MAGA’s future

A whirlwind Friday is the freshest reminder that the MAGA movement has always been defined more by id than ideology.